Clifton R. LaDuane
SEC CIK 1488774 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZVRA | ZEVRA THERAPEUTICS, INC. | Former CFO, Treas | 143.5K | $71.3K | $86.5K | 15 | 2021-09-01 | 2025-12-31 |
Most active insiders at ZVRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McFarlane Neil F. | Pres, CEO, Dir | — | $1.19M |
| 2 | Thompson Rahsaan | Chief Legal, Compliance, Sec | — | $969.4K |
| 3 | Watton Corey Michael | Dir | — | $138.4K |
| 4 | Schafer Joshua | CCO | — | $126.3K |
| 5 | Sangiovanni Timothy J. | SVP, Fin, Corp Ctrl | — | $43.0K |
| 6 | Quartel Adrian W | Chief Medical Off | — | $40.0K |
| 7 | Bode John B | Dir | — | — |
| 8 | Clifton R. LaDuane | Former CFO, Treas | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-07 | 2025-12-31 | ZVRA | ZEVRA THERAPEUTICS, INC. | Clifton R. LaDuane | Former CFO, Treas | F - Tax | $8.96 | -48.5K | 143.5K | -25% | -$434.7K |
| D | 2026-01-07 | 2025-12-31 | ZVRA | ZEVRA THERAPEUTICS, INC. | Clifton R. LaDuane | Former CFO, Treas | M - OptEx | $0.00 | +140.7K | 192.0K | +274% | $0 |
| 2025-02-14 | 2025-02-13 | ZVRA | ZEVRA THERAPEUTICS, INC. | Clifton R. LaDuane | CFO, Treas | S - Sale | $7.86 | -11.0K | 51.4K | -18% | -$86.5K | |
| D | 2025-02-03 | 2025-01-31 | ZVRA | ZEVRA THERAPEUTICS, INC. | Clifton R. LaDuane | CFO, Treas | M - OptEx | — | +43.3K | 62.4K | +228% | — |
| 2024-07-17 | 2024-07-17 | ZVRA | ZEVRA THERAPEUTICS, INC. | Clifton R. LaDuane | CFO, Treas | P - Purchase | $6.77 | +2,000 | 18.5K | +12% | +$13.5K | |
| 2023-09-06 | 2023-09-06 | ZVRA | ZEVRA THERAPEUTICS, INC. | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $4.96 | +1,000 | 15.3K | +7% | +$4,960 | |
| M | 2023-05-18 | 2023-05-18 | ZVRA | ZEVRA THERAPEUTICS, INC. | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $4.95 | +2,740 | 13.7K | +25% | +$13.6K |
| 2023-03-13 | 2023-03-10 | ZVRA | ZEVRA THERAPEUTICS, INC. | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $4.15 | +1,725 | 11.0K | +19% | +$7,159 | |
| M | 2023-01-13 | 2023-01-13 | ZVRA | ZEVRA THERAPEUTICS, INC. | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $5.81 | +635 | 9,277 | +7% | +$3,690 |
| M | 2022-10-03 | 2022-09-30 | ZVRA | ZEVRA THERAPEUTICS, INC. | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $5.98 | +1,000 | 7,709 | +15% | +$5,980 |
| 2022-05-18 | 2022-05-18 | ZVRA | ZEVRA THERAPEUTICS, INC. | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $5.00 | +1,200 | 6,440 | +23% | +$6,000 | |
| 2021-11-18 | 2021-11-18 | ZVRA | ZEVRA THERAPEUTICS, INC. | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $8.29 | +510 | 5,240 | +11% | +$4,228 | |
| 2021-09-29 | 2021-09-29 | ZVRA | ZEVRA THERAPEUTICS, INC. | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $9.38 | +215 | 4,730 | +5% | +$2,017 | |
| 2021-09-20 | 2021-09-20 | ZVRA | ZEVRA THERAPEUTICS, INC. | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $8.59 | +935 | 4,515 | +26% | +$8,032 | |
| 2021-09-01 | 2021-09-01 | ZVRA | ZEVRA THERAPEUTICS, INC. | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $9.11 | +230 | 3,580 | +7% | +$2,095 |
Purchase Sale Sale after option exercise All abbreviations